| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 10/11/2006 | CN1845911A Condensed ring compound and use thereof |
| 10/11/2006 | CN1845909A Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
| 10/11/2006 | CN1845905A PPAR-activating compound and pharmaceutical composition comprising the compound |
| 10/11/2006 | CN1845900A Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 10/11/2006 | CN1845734A Benzimidazole derivatives and their use as protein kinases inhibitors |
| 10/11/2006 | CN1279034C Dna－pk抑制剂 Dna-pk inhibitors |
| 10/11/2006 | CN1279026C Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 10/10/2006 | US7119214 dibenzofuranyl, dibenzothiophenyl or fluorenyl thioacetamides used for prophylaxis of sleep disorders |
| 10/10/2006 | US7119207 NK-1 receptor antagonists, (e.g., substance P receptor antagonists) |
| 10/10/2006 | US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 10/10/2006 | US7119201 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 10/10/2006 | US7119198 beta-aryl-alpha-oxysubstituted alkylcarboxylic acids, usch as Ethyl (E/Z)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropenoate, used as antilipemic or hypoglycemic agents |
| 10/10/2006 | US7119120 A 2-benzenesulfonylamino-N-benzyl-benzamides for treating hyperphosphatemia, urogential disorders |
| 10/10/2006 | US7119116 Direct aminolysis of a carbamate ester or hydrolysis to an acid followed by coupling with an amine; analgesics, disorders of eating, nervous system, psychology, sleep, urogenital, respiratory and gastrointestinal systems; antiischemic, anticarcinogenic, antiinflammatory agents, antiallergens |
| 10/10/2006 | US7119115 For therapy of treating tumors or cancerous cells |
| 10/10/2006 | US7119113 optionally halogenated N-(trifluoromethyloxazol-2-yl)xanthene-9-carboxamides; treatment of neurological disorders such as Alzheimer's disease and dementia |
| 10/10/2006 | US7119105 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors |
| 10/10/2006 | US7119104 Alpha-(oxy-, sulfo- or amino-)[3-(imidazolyl, oxazolyl or thiazolyl)alkylene(indazolyl, benzisoxazolyl or benzisothiazolyl)]acetic acids, esters or alkali salts |
| 10/10/2006 | US7119102 3-amino-6-{4-[2-hydroxy-2-(substituted heteroaryl)ethylamino]-piperidin-1-yl}thieno[2,3-b]pyridine-2-carboxylic acid amides; reductive amination; I kappa B kinase inhibitors; autoimmune diseases; antiinflammatory and anticarcinogenic agents |
| 10/10/2006 | US7119099 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives |
| 10/10/2006 | US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases |
| 10/10/2006 | US7119090 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases, enzyme inhibitors |
| 10/10/2006 | US7119088 A bi-heterocycle-4H-2,3,5,10b-tetraaza-benzo[e]azulene derivatives; for therapy of dysmenorrhoea, anxiety disorder, asthma, atherosclerosis, cardiac failure, cardiovascular disease, cataract, central nervous system disease, motion sickness, Raynaud's disease, rheumatoid arthritis; chemical synthesis |
| 10/10/2006 | US7119084 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders |
| 10/10/2006 | US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 10/10/2006 | US7118811 Materials for light emitting devices consisting of novel compounds and light emitting devices using the same |
| 10/10/2006 | CA2418778C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
| 10/10/2006 | CA2274594C Aminopyrazole derivatives |
| 10/10/2006 | CA2255951C Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 10/10/2006 | CA2158862C Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 10/05/2006 | WO2006105289A1 Bicyclic pyrazole compounds as antibacterial agents |
| 10/05/2006 | WO2006105262A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl |
| 10/05/2006 | WO2006104280A1 Prophylactic/therapeutic agent for diabetes |
| 10/05/2006 | WO2006104141A1 3-propenylcephem derivative |
| 10/05/2006 | WO2006104008A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 10/05/2006 | WO2006103511A1 Cyclopentapyridine and tetrahydroquinoline derivatives |
| 10/05/2006 | WO2006103277A2 2 , 4 , 5-substituted piperidines as renin inhibitors |
| 10/05/2006 | WO2006103275A1 3,4,5-substituted piperidines as renin inhibitors |
| 10/05/2006 | WO2006103273A1 Substituted piperidines as renin inhibitors |
| 10/05/2006 | WO2006103120A2 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| 10/05/2006 | WO2006103057A1 Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses |
| 10/05/2006 | WO2006103045A1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| 10/05/2006 | WO2006102760A1 Inhibitors of histone deacetylase |
| 10/05/2006 | WO2006078621A3 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 10/05/2006 | WO2006071609A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 10/05/2006 | WO2006059245A3 Compounds for the treatment of cns and amyloid associated diseases |
| 10/05/2006 | WO2006058012A3 Gonadotropin releasing hormone receptor antagonists |
| 10/05/2006 | WO2006047196A3 Cgrp receptor antagonists |
| 10/05/2006 | WO2006044825A3 Mitotic kinesin inhibitors and methods of use thereof |
| 10/05/2006 | WO2005115392A8 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors |
| 10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/05/2006 | US20060223996 IL-12 modulatory compounds |
| 10/05/2006 | US20060223890 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 10/05/2006 | US20060223873 Isoxazole derivatives and methods of treating nitric oxide mediated diseases |
| 10/05/2006 | US20060223850 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors |
| 10/05/2006 | US20060223849 Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors |
| 10/05/2006 | US20060223848 Caspase inhibitors containing isoxazoline ring |
| 10/05/2006 | US20060223822 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 10/05/2006 | US20060223808 Spirocyclic thrombin receptor antagonists |
| 10/05/2006 | US20060223804 NK1 antagonists |
| 10/05/2006 | US20060223802 Derivatives of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide and N-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 10/05/2006 | US20060223801 Pyrrol derivatives with antibacterial activity |
| 10/05/2006 | US20060223746 Injecting an alpha v beta 3 and/or alpha v beta 5 inhibitor, sufficient to inhibit or reduce angiogenesis or neovascularization in the treated eye, into the sclera layer of the eye; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 10/05/2006 | US20060223151 Production of polyketides |
| 10/05/2006 | US20060223076 Cyanine dyes and their applications as luminescence quenching compounds |
| 10/05/2006 | DE102005000666B3 Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Sulfonylpyrrolidine, processes for their preparation and their use as medicaments |
| 10/05/2006 | CA2603589A1 Inhibitors of histone deacetylase |
| 10/05/2006 | CA2603345A1 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| 10/05/2006 | CA2603322A1 Bicyclic pyrazole compounds as antibacterial agents |
| 10/05/2006 | CA2602546A1 Novel compounds |
| 10/05/2006 | CA2602351A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 10/05/2006 | CA2602339A1 Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses |
| 10/05/2006 | CA2602336A1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| 10/05/2006 | CA2602257A1 Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors |
| 10/05/2006 | CA2602254A1 Pharmacokinetically improved compounds |
| 10/05/2006 | CA2601702A1 2, 4, 5-substituted piperidines as renin inhibitors |
| 10/05/2006 | CA2601699A1 Substituted piperidines |
| 10/05/2006 | CA2601108A1 3,4,5-substituted piperidines as renin inhibitors |
| 10/04/2006 | EP1706409A1 Compounds useful in therapy |
| 10/04/2006 | EP1706402A1 Cathepsin cysteine protease inhibitors |
| 10/04/2006 | EP1706398A1 Amino-benzazoles as p2y1 receptor inhibitors |
| 10/04/2006 | EP1706396A1 N-(4-carbamimidoyl-benzyl)-2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 10/04/2006 | EP1706390A2 Isoxazole derivatives and their use as cyclooxygenase inhibitors |
| 10/04/2006 | EP1706385A1 Pyrazole derivatives as protein kinase modulators |
| 10/04/2006 | EP1706372A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 10/04/2006 | EP1706129A1 Drug therapy for celiac sprue |
| 10/04/2006 | EP1705989A1 Substituted arylpyrazoles as parasiticidal agents |
| 10/04/2006 | EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 10/04/2006 | EP1372653B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 10/04/2006 | CN1842522A Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 10/04/2006 | CN1842521A Caspase inhibitors containing isoxazoline ring |
| 10/04/2006 | CN1842336A Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| 10/04/2006 | CN1842272A Hydrazone derivatives for combatting harmful insects and arachnids |
| 10/04/2006 | CN1277829C 3, 5-disubstituted-oxazolidine with antibiotic activity, its preparation method and use |
| 10/04/2006 | CN1277824C Piperazine derivatives |
| 10/04/2006 | CN1277820C Phthalimido derivatives as inhibitors of monoamine oxidase B |
| 10/03/2006 | US7115750 Melanin concentrating hormone antagonist |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115658 Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus. |
| 10/03/2006 | US7115654 Caspase-1 inhibitors and methods for their use |